相关实验视频

Updated: Jan 9, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

向MAO提供了一种针对前列腺癌的新型免疫治疗策略,通过调节"瘤-肌瘤-免疫"相互作用网络来调节

Yaohua Hu¹, Zhite Zhao², Yifan Ma³

¹Division of Cancer Biology, Laboratory Animal Center, Fourth Military Medical University, Xi'an, Shaanxi 710032, China; State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Xi'an, Shaanxi 710032, China.

Biochimica et biophysica acta. Reviews on cancer

|December 6, 2025

概括

向单胺氧化酶 (MAO) 可以克服前列腺癌 (PCa) 中的免疫疗法耐药性. 马奥抑制剂可以通过调节瘤微环境和PCa中的免疫细胞相互作用来改善治疗.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物化学生物化学

背景情况:

前列腺癌 (PCa) 是一种普遍存在的恶性瘤,具有很高的异质性和免疫抑制瘤微环境 (TME),导致治疗失败.
抗化前列腺癌 (CRPC) 的进展,转移和神经内分泌分化带来了重大的治疗挑战.
在TME内部的复杂相互作用,涉及瘤细胞,肌层和免疫成分,有助于PCa的低免疫性.

研究的目的:

为了澄清单胺氧化酶 (MAO) 在调节PCa进展中的瘤-瘤-免疫网络中的作用.
阐明MAO对CD8+T细胞透和TME内的瘤相关巨细胞 (TAM) 极化的影响.
建议精确准MAO作为一种克服PCa免疫疗法耐药性的策略.

主要方法:

对PCa.中MAO表达和功能的现有文献的审查.
对MAO对TME免疫细胞透和极化影响的分析.
探索PCa免疫治疗中基于MAO抑制剂的治疗策略.

主要成果:

通过其MAOA和MAOB异构体,MAO在PCa细胞,树皮细胞和免疫细胞中具有差异性表达.
马奥的活性影响"瘤-肌瘤-免疫"相互作用网络,可能促进PCa的进展.
MAO影响CD8+T细胞透和TAM极化,这是TME免疫抑制性质的关键因素.

结论:

向MAO提供了一个有希望的策略,以提高PCa的免疫疗法疗效.
马奥抑制剂可以通过调节TME和免疫反应来克服免疫疗法耐药性.
本综述为开发基于MAO抑制剂的新型干预措施提供了理论基础,用于有效的PCa免疫疗法.

关键词:

免疫治疗是一种免疫疗法.抑制剂的抑制剂一种单胺氧化酶 (monoamine oxidase) 的存在前列腺癌是什么意思前列腺癌是什么意思瘤微环境是一个微环境.

更多相关视频

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...